- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07419555
Belgiska lungfunktionsstudien (AIRCAST)
Belgisk Lungfunktionsstudie: Personlig Longitudinell Lungfunktionsanalys som Markör för Sjukdomsprogression
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.
A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
The objective of this study is to explore the clinical value of models predicting longitudinal lung function patterns in individuals with chronic respiratory diseases across Belgium.
- The investigators will assess the accuracy of individualised lung function prediction models in a multicentre lung function dataset with prospective clinical and lung function follow-up.
- The investigators will evaluate important health outcomes, step-up in care, patient-reported outcomes in individuals identified with an expected and unexpected observed trajectory as compared to the predicted population and individualised trajectory.
The hypothesis is that patients with an unexpected decline in lung function will have worse health outcomes, such as a higher mortality rate and more hospitalisations, compared to patients with an expected lung function pattern. The investigators hypothesise to observe better health outcomes and lower mortality rates in patients with an unexpectedly positive lung function evolution compared to patients with an expected negative lung function pattern.
Individuals will be recruited from 4 Belgian Hospitals (UZ Leuven, UZ Antwerpen, AZ Delta, ZOL Genk). Based on the annual rate of pulmonary function testing in these hospitals, a sample size of 1.000 participants per centre is anticipated within one year of inclusions, resulting in a total sample size of 4.000 patients.
All available historical lung function data of included individuals will be retrieved from the individuals medical file. Additionally, the individual will be prospectively followed for 2 years where all lung function data will be collected.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Marieke Wuyts
- Telefonnummer: 016 34 31 59
- E-post: marieke.wuyts@kuleuven.be
Studieorter
-
-
-
Edegem, Belgien, 2650
- Rekrytering
- UZ Antwerpen
-
Kontakt:
- Therese Lapperre
- Telefonnummer: 0032 3 821 5089
- E-post: therese.lapperre@uza.be
-
Huvudutredare:
- Therese Lapperre
-
Underutredare:
- Kevin De Soomer
-
Genk, Belgien, 3600
- Rekrytering
- Ziekenhuis Oost-Limburg
-
Kontakt:
- David Ruttens
- Telefonnummer: 0032 89 80 52 00
- E-post: david.ruttens@zol.be
-
Huvudutredare:
- David Ruttens
-
Underutredare:
- Maarten Criel
-
Ghent, Belgien
- Rekrytering
- UZ Gent
-
Huvudutredare:
- Eric Derom
-
Kontakt:
- Eric Derom
- Telefonnummer: 0032 9 332 23 42
- E-post: Eric.Derom@uzgent.be
-
Underutredare:
- Lies Lahousse
-
Leuven, Belgien, 3000
- Rekrytering
- UZ Leuven
-
Huvudutredare:
- Wim Janssens
-
Kontakt:
- Marieke Wuyts
- Telefonnummer: 016 34 31 59
- E-post: marieke.wuyts@kuleuvne.be
-
Roeselare, Belgien, 8800
- Rekrytering
- AZ Delta
-
Huvudutredare:
- Ingel Demedts
-
Kontakt:
- Ingel Demedts
- Telefonnummer: 0032 51 23 41 16
- E-post: ingel.demedts@azdelta.be
-
Underutredare:
- Bernard Bouckaert
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Chronic respiratory diseases
Beskrivning
Inclusion Criteria:
- Above 18 years old
- Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
- Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
- Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
- Planned routine follow-up within standard clinical care in one of the participating hospitals
Exclusion Criteria:
- Patients who have had a lung transplantation
- Patients not being able to give consent to participate
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Accuracy of lung function predictions (FEV1)
Tidsram: at 1 and 2-year follow-up
|
Proportion of correct and incorrect FEV1 predictions compared to the observed measure |
at 1 and 2-year follow-up
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Differences in clinical outcomes between correct and incorrect lung function predictions (FEV1)
Tidsram: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FEV1 on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care |
at 1 and 2-year follow-up
|
|
Accuracy of lung function predictions
Tidsram: at 1 and 2-year follow-up
|
Proportion of correct and incorrect lung function predictions (FVC, TLC, RV/TLC, DLCO) compared to the observed measure |
at 1 and 2-year follow-up
|
|
Differences in clinical outcomes between correct and incorrect lung function predictions
Tidsram: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FVC, TLC, RV/TLC, DLCO on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care) |
at 1 and 2-year follow-up
|
|
Identifying the minimal needed to make predictions
Tidsram: after 2 years
|
Minimal number of tests/length of follow-up required for optimal predictions |
after 2 years
|
|
Performance of ML-based predictions compared to linear regression analysis
Tidsram: at 1 and 2-year follow-up
|
Comparison of the ML-based predictions for individual and population lung function changes with predictions based on linear regression on individual historical data |
at 1 and 2-year follow-up
|
|
Overall description of population
Tidsram: baseline, 1 and 2-year follow-up
|
Sociodemographic information, health status, comorbidities, frailty, disease labels, interventions and prognosis of individuals with a chronic respiratory disease |
baseline, 1 and 2-year follow-up
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Wim Janssens, UZ/KU Leuven
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- S70923
- C2M25045 (Annat bidrag/finansieringsnummer: Internal funding KULeuven)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .